Pulmonary Arterial Hypertension

Prognostic biomarkers ID'd in pulmonary hypertension

(HealthDay)—Biomarkers have been identified for the risk of lung transplantation and death in patients with pulmonary arterial hypertension (PAH), according to a study published online Oct. 26 in the Annals of the American ...

Nov 18, 2015
popularity8 comments 0

Uptravi approved for chronic lung disease

(HealthDay)—Uptravi (selexipag) has been approved by the U.S. Food and Drug Administration to treat adults with pulmonary arterial hypertension, a disabling lung disease that often leads to death or the need for lung transplant.

Dec 22, 2015
popularity1 comments 0

In medicine, pulmonary hypertension (PH) is an increase in blood pressure in the pulmonary artery, pulmonary vein, or pulmonary capillaries, together known as the lung vasculature, leading to shortness of breath, dizziness, fainting, and other symptoms, all of which are exacerbated by exertion. Pulmonary hypertension can be a severe disease with a markedly decreased exercise tolerance and heart failure. It was first identified by Dr. Ernst von Romberg in 1891. According to the most recent classification, it can be one of five different types: arterial, venous, hypoxic, thromboembolic or miscellaneous.

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

The neuroscience of seeking company

Social animals are strongly motived to seek out the company of others, especially after periods of isolation, because their brains are wired to find it rewarding. A study in mice published February 11 in Cell now reveals ...

Why smiles (and frowns) are contagious

Smile! It makes everyone in the room feel better because they, consciously or unconsciously, are smiling with you. Growing evidence shows that an instinct for facial mimicry allows us to empathize with and even experience ...